Skip to main navigation Skip to search Skip to main content

A Phase 1b, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of AEVI-007 in Subjects with Adult Onset Still's Disease

Project: Research

Project Details

StatusFinished
Effective start/end date06/22/2105/18/22

Funding

  • Cerecor: $11,250.00